Abstract:
The present invention provides novel 13,14-dihydro-inter-3,7-inter-m-phenylene-4,5,6-trinor-3-oxa-19-oxo-PGE.sub.1 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.

Description:
DESCRIPTION 
     CROSS REFERENCE TO RELATED APPLICATION 
     This application is a division of Ser. No. 025,879, filed Apr. 2, 1979, now pending now U.S. Pat. No. 4,228,104. 
    
    
     BACKGROUND OF THE INVENTION 
     The present invention relates to novel prostaglandin analogs. Particularly, the invention relates to prostaglandin analogs wherein the C-19 position is substituted by oxo, i.e., 19-keto-PG compounds or 19-oxo-PG compounds. Most particularly, the present invention relates to novel 13,14-dihydro-inter-phenylene-19-oxo-PGE 1  compounds, a disclosure of the preparation and pharmacological use of which is incorporated here by reference from U.S. Pat. No. 4,228,104. 
     PRIOR ART 
     Prostaglandins exhibiting a variety of substitution at the C-19 position are known. See particularly J. C. Sih, et al., JACS 91:3685 (1969) wherein 19-oxo-PGE 2  and 13,14-dihydro-19-oxo-PGE 1  are disclosed. Further, Chemical Abstracts 86:43265H purportedly discloses 19-oxo-PGF 2  α. The abstract is derived from Japanese Kokai 76 82,245. 
     SUMMARY OF THE INVENTION 
     The present invention particularly provides: a compound of the formula ##STR1## wherein D is (1) --(m-Ph)-(CH 2 ) 2  --, or 
     (2) --(m-Ph)--O--CH 2  --, 
     wherein 
     --(m-Ph)-- is inter-meta-phenylene; 
     wherein Q is α-OH:β-R 5  or α-R 5  :β-OH, wherein R 5  is hydrogen or methyl; 
     wherein R 6  is 
     (a) hydrogen, 
     (b) alkyl of one to 12 carbon atoms, inclusive, 
     (c) cycloalkyl of 3 to 10 carbon atoms, inclusive, 
     (d) aralkyl of 7 to 12 carbon atoms, inclusive, 
     (e) phenyl, 
     (f) phenyl substituted with one, 2, or 3 chloro or alkyl groups of one to 3 carbon atoms, inclusive, 
     (g) --(p-Ph)--CO--CH 3 , 
     (h) --(p-Ph)--NH--CO--(p-Ph)--NH--CO--CH 3 , 
     (i) --(p-Ph)--NH--CO--(p-Ph), 
     (j) --(p-Ph)--NH--CO--CH 3 , 
     (k) --(p-Ph)--NH--CO--NH 2 , 
     (l) --(p-Ph)--CH═N--NH--CO--NH 2 , 
     (m) β-naphthyl, 
     --CH 2  --CO--R 28 , 
     wherein (p-Ph) is para-phenyl or inter-para-phenylene, wherein R 28  is phenyl, p-bromophenyl, p-biphenylyl, p-nitrophenyl, p-benzamidophenyl, or 2-naphthyl, or 
     (o) a pharmacologically acceptable cation; 
     wherein R 3  and R 4  are hydrogen, methyl, or fluoro, being the same or different, with the proviso that one of R 3  and R 4  is fluoro only when the other is hydrogen or fluoro; and 
     wherein X is --CH 2  CH 2  --. 
     The compounds of the present invention are particularly useful for inducing prostaglandin-like biological effects, as described in United States Ser. No. 026,066. Uses of compounds in accordance with the present invention include, therefore, antiasthmatic indications. 
    
    
     DESCRIPTION OF THE PREFERRED EMBODIMENTS 
     The present invention particularly relates to: 
     13,14-dihydro-3,7-inter-m-phenylene-4,5,6-trinor-3-oxa-19-oxo-PGE 1  ; and 
     13,14-dihydro-3,7-inter-m-phenylene-4,5,6-trinor-3-oxa-15(R)-19-oxo-PGE.sub.1.